相似文献
1
Genomic medicine, precision medicine, personalized medicine: what's in a name?
Clin Pharmacol Ther. 2013 Aug;94(2):169-72. doi: 10.1038/clpt.2013.101.
2
Genomic medicine, health information technology, and patient care.
JAMA. 2013 Apr 10;309(14):1467-8. doi: 10.1001/jama.2013.1414.
3
Bench-to-Bedside; Clinical and Translational Research; Personalized Medicine; Precision Medicine-What's in a Name?
Clin Transl Sci. 2015 Jun;8(3):171-3. doi: 10.1111/cts.12302.
4
Toward clinical genomics in everyday medicine: perspectives and recommendations.
Expert Rev Mol Diagn. 2016;16(5):521-32. doi: 10.1586/14737159.2016.1146593. Epub 2016 Feb 24.
5
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Scand J Clin Lab Invest Suppl. 2016;245:S84-91. doi: 10.1080/00365513.2016.1210331. Epub 2016 Aug 17.
6
Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
Trends Genet. 2017 Feb;33(2):118-128. doi: 10.1016/j.tig.2016.11.006. Epub 2016 Dec 22.
7
Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Mol Biosyst. 2016 May 24;12(6):1818-30. doi: 10.1039/c6mb00115g.
8
Maps for the world of genomic medicine: the 2011 CSHL Personal Genomes meeting.
Hum Mutat. 2012 Jun;33(6):1016-9. doi: 10.1002/humu.22024. Epub 2012 Apr 16.
9
Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
Annu Rev Genomics Hum Genet. 2017 Aug 31;18:229-256. doi: 10.1146/annurev-genom-083115-022545. Epub 2017 Apr 17.
10
[Genomic medicine].
Ugeskr Laeger. 2019 Apr 1;181(7A).
引用本文的文献
1
A Two-color Single-molecule Sequencing Platform and Its Clinical Applications.
Genomics Proteomics Bioinformatics. 2024 May 9;22(1). doi: 10.1093/gpbjnl/qzae006.
2
Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.
Cells. 2024 Mar 13;13(6):504. doi: 10.3390/cells13060504.
3
Genetic diversity of variants involved in drug response among Tunisian and Italian populations toward personalized medicine.
Sci Rep. 2024 Mar 10;14(1):5842. doi: 10.1038/s41598-024-55239-7.
4
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review.
Front Pharmacol. 2023 Sep 19;14:1267294. doi: 10.3389/fphar.2023.1267294. eCollection 2023.
5
Pharmacogenetics of Anticancer Drugs: Clinical Response and Toxicity.
Cancer Treat Res. 2023;185:141-175. doi: 10.1007/978-3-031-27156-4_9.
6
Genomic medicine on the frontier of precision medicine.
J Diabetes Metab Disord. 2021 Aug 24;21(1):853-861. doi: 10.1007/s40200-021-00880-6. eCollection 2022 Jun.
7
Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease.
PLoS One. 2022 Feb 23;17(2):e0263248. doi: 10.1371/journal.pone.0263248. eCollection 2022.
8
Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis.
BMC Med Ethics. 2021 Aug 31;22(1):116. doi: 10.1186/s12910-021-00682-8.
9
Personalized Medicine in Undergraduate Medical Education: a Spiral Learning Model.
Med Sci Educ. 2020 Aug 26;30(4):1741-1744. doi: 10.1007/s40670-020-01066-0. eCollection 2020 Dec.
10
Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights.
J Cell Mol Med. 2021 Sep;25(18):8602-8614. doi: 10.1111/jcmm.16875. Epub 2021 Aug 23.
本文引用的文献
1
Educational challenges in implementing genomic medicine.
Clin Pharmacol Ther. 2013 Aug;94(2):192-5. doi: 10.1038/clpt.2013.38.
2
Genomic testing: the clinical laboratory perspective.
Clin Pharmacol Ther. 2013 Aug;94(2):190-2. doi: 10.1038/clpt.2013.61.
3
Genomic medicine: too great expectations?
Clin Pharmacol Ther. 2013 Aug;94(2):188-90. doi: 10.1038/clpt.2013.44.
4
CYP2D6 genotype and tamoxifen activity: understanding interstudy variability in methodological quality.
Clin Pharmacol Ther. 2013 Aug;94(2):185-7. doi: 10.1038/clpt.2013.66.
5
CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients.
Clin Pharmacol Ther. 2013 Aug;94(2):183-5. doi: 10.1038/clpt.2013.102.
6
The opportunities and challenges of implementing genomics-informed personalized medicine.
Clin Pharmacol Ther. 2013 Aug;94(2):181-2. doi: 10.1038/clpt.2013.71.
7
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future.
Genet Med. 2013 Oct;15(10):761-71. doi: 10.1038/gim.2013.72. Epub 2013 Jun 6.
8
Challenges in the pharmacogenomic annotation of whole genomes.
Clin Pharmacol Ther. 2013 Aug;94(2):211-3. doi: 10.1038/clpt.2013.111. Epub 2013 May 24.
9
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
Clin Pharmacol Ther. 2013 Sep;94(3):317-23. doi: 10.1038/clpt.2013.105. Epub 2013 May 22.
10
A systematic approach to the development of novel therapeutics for lung cancer using genomic analyses.
Clin Pharmacol Ther. 2013 Aug;94(2):218-23. doi: 10.1038/clpt.2013.90. Epub 2013 May 8.
Zotero 插件